GOCOVRI 137 mg/1

GOCOVRI 137 mg/1 is a coated pellet capsule containing amantadine, used for managing symptoms of certain neurological conditions. This medication is designed for oral administration and is manufactured by Supernus Pharmaceuticals in the USA.

GOCOVRI 137 mg/1 is primarily used to help manage symptoms associated with specific neurological disorders. It is often prescribed to address conditions that involve involuntary movements or muscle stiffness. The medication works by affecting certain chemicals in the brain, which can help improve motor control and reduce symptoms. People often ask, 'What is GOCOVRI used for?' and it is typically utilized for conditions that require long-term management of movement-related symptoms.

Common effects of GOCOVRI 137 mg/1 may include improvements in motor function and a reduction in involuntary movements. Some users may experience side effects such as dizziness, dry mouth, or constipation. It is important to note that individual responses to the medication can vary, and not everyone will experience the same effects.

GOCOVRI 137 mg/1 should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies. Always consult a healthcare provider before starting or stopping any medication.

GOCOVRI 137 mg/1 may interact with other medications, including those that affect the central nervous system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also interact with this medication, so it is important to discuss lifestyle factors with your healthcare provider.